FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vinblastine 12mg/50ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 2g solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2b 1million unit powder and solvent for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vincristine 5mg/5ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Rucaparib 250mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Epirubicin 50mg/25ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinblastine 8.2mg/50ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinorelbine 10mg/1ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 240mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Etoposide 200mg/10ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Treosulfan 5g powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Nilotinib 50mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinblastine 9mg/50ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitoxantrone 25mg/12.5ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 22.5mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bicalutamide 50mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bortezomib 3.5mg/1.4ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pertuzumab 420mg/14ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 17.5mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 950mg/47.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Epirubicin 90mg/45ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 25mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 2500mg/130ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 150mg/15ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 2.4million units/0.2ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dasatinib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 2128mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 25mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bortezomib 2.5mg powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 113mg/1000ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Oxaliplatin 225mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2a (rbe) 9million units/0.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1900mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 120mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Oxaliplatin 100mg/20ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 5g/200ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 15mg/0.6ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cytarabine 20mg/0.2ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 1120mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 25mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 500mg/20ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lenvatinib 10mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 2.2g/220ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Epirubicin 5mg/2.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tioguanine 10mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 5000mg/130ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alitretinoin 10mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 90mg/3.6ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 300mg/15ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 25mg/0.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 25mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dacarbazine 600mg powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 160mg/8ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon alfa-2b 50microgram powder and solvent for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 50mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 60mg/2.4ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 10mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 250mg/5ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1300mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 45mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 12.5mg/0.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Etoposide 100mg/5ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cytarabine 4g/40ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Olaparib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 2.4million units/0.2ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Hydroxycarbamide 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 15mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 12million units/0.5ml solution for injection pre-filled syringes Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 2000mg/105ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 5000mg/300ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Streptozocin 1g powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 500mg/20ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Temozolomide 140mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 500mg/20ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Oxaliplatin 150mg powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 22.5mg/0.9ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Leuprorelin 11.25mg powder and solvent for suspension for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon alfa-2b 100microgram powder and solvent for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 500mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 2.5mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bortezomib 1.6mg/0.64ml in Sodium chloride 0.9% solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lenalidomide 15mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Axitinib 3mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Doxorubicin 20mg/10ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 6million units/0.5ml solution for injection pre-filled syringes Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Epirubicin 10mg/5ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2b 25million units/2.5ml solution for injection multidose vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Aldesleukin 18million unit powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Afatinib 30mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Topotecan 1mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Imatinib 400mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ofatumumab 20mg/0.4ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Afatinib 20mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bosutinib 500mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Anagrelide 500microgram capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pazopanib 400mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 23 of 26 Next End

This concept is not in any reference sets

Back to Start